KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Total Liabilities (2016 - 2025)

Charles River Laboratories International has reported Total Liabilities over the past 17 years, most recently at $3.9 billion for Q4 2025.

  • Quarterly results put Total Liabilities at $3.9 billion for Q4 2025, down 2.39% from a year ago — trailing twelve months through Dec 2025 was $3.9 billion (down 2.39% YoY), and the annual figure for FY2025 was $3.9 billion, down 2.39%.
  • Total Liabilities for Q4 2025 was $3.9 billion at Charles River Laboratories International, down from $4.1 billion in the prior quarter.
  • Over the last five years, Total Liabilities for CRL hit a ceiling of $4.8 billion in Q2 2022 and a floor of $3.6 billion in Q1 2021.
  • Median Total Liabilities over the past 5 years was $4.4 billion (2021), compared with a mean of $4.3 billion.
  • Biggest five-year swings in Total Liabilities: surged 341.59% in 2021 and later dropped 11.37% in 2024.
  • Charles River Laboratories International's Total Liabilities stood at $4.4 billion in 2021, then increased by 3.32% to $4.6 billion in 2022, then dropped by 0.94% to $4.5 billion in 2023, then decreased by 11.37% to $4.0 billion in 2024, then decreased by 2.39% to $3.9 billion in 2025.
  • The last three reported values for Total Liabilities were $3.9 billion (Q4 2025), $4.1 billion (Q3 2025), and $4.2 billion (Q2 2025) per Business Quant data.